Effects of hydroxyethyl starch solutions on hemostasis

Anesthesiology

Volumn 103, Issue 3, 2005, Pages 654-660

  Kozek Langenecker, Sibylle A ^a  

^a MEDICAL UNIVERSITY OF VIENNA   (Austria)

Author keywords

[No Author keywords available]

Indexed keywords

BLOOD CLOTTING FACTOR 8; HETASTARCH; PLASMA SUBSTITUTE; VON WILLEBRAND FACTOR;

DRUG EFFECT; FIBRIN FORMATION; FIBRIN POLYMERIZATION; FIBRINOLYSIS; HEMODYNAMIC MONITORING; HEMOSTASIS; HIGH RISK PATIENT; OSMOTIC PRESSURE; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; THROMBOCYTE ACTIVATION; THROMBOCYTE FUNCTION; TISSUE PERFUSION;

EID: 24144488638     PISSN: 00033022     EISSN: 15281175     Source Type: Journal    
DOI: 10.1097/00000542-200509000-00031     Document Type: Review

References (46)

1. Treib J, Baron JF, Grauer MT, Strauss RG: An international view of hydroxyethyl starches. Intensive Care Med 1999; 25:258-68
2. Jung F, Koscielny J, Mrowietz C, Forster H, Schimetta W, Kiesewetter H, Wenzel E: The effects of molecular structure of hydroxyethyl starch on the elimination kinetics and fluidity of blood in human volunteers (in German). Arzneimittelforschung 1993; 43:99-105
3. Treib J, Haass A, Pindur G, Seyfert UT, Treib W, Grauer MT, Jung F, Wenzel E, Schimrigk K: HES 200/0.5 is not HES 200/0.5: Influence of the C2/C6 hydroxyethylation ratio of hydroxyethyl starch (HES) on hemorheology, coagulation and elimination kinetics. Thromb Haemost 1995; 74:1452-6
4. Treib J, Haass A, Pindur G, Grauer MT, Wenzel E, Schimrigk K: All medium starches are not the same: influence of the degree of hydroxyethyl substitution of hydroxyethyl starch on plasma volume, hemorrheologic conditions, and coagulation. Transfusion 1996; 36:450-5
5. Treib J, Haass A, Pindur G: Coagulation disorders caused by hydroxyethyl starch. Thromb Haemost 1997; 78:974-83
6. Jungheinrich C, Sauermann W, Bepperling F, Vogt NH: Volume efficacy and reduced influence on measures of coagulation using hydroxyethyl starch 130/0.4 (6%) with an optimised in vivo molecular weight in orthopedic surgery: A randomised, double-blind study. Drugs R D 2004; 5:1-9
7. Laxenaire MC, Carpentier C, Feldman L: Anaphylactoid reactions to colloid plasma substitutes: Incidence, risk factors, mechanisms: A French multicenter prospective study [in French]. Ann Fr Anesth Reanim 1994; 13:301-10
8. Dietrich HJ, Kraft D, Sirtl C, Laubenthal H, Schimetta W, Polz W, Gerlach E, Peter K: Hydroxyethyl starch antibodies in humans: Incidence and clinical relevance. Anesth Analg 1998; 86:1123-6
9. Treib J, Haass A, Pindur G, Treib W, Wenzel E, Schimrigk K: Influence of intravascular molecular weight of hydroxyethyl starch on platelets. Eur J Haematol 1996; 56:168-72
10. de Jonge E, Levi M, Buller R, Berends F, Kesecioglu J: Decreased circulating levels of von Willebrand factor after intravenous administration of a rapidly degradable hydroxyethyl starch (HES 200/0.5/6) in healthy human subjects. Intensive Care Med 2001; 27:1825-9
11. Jamnicki M, Bombeli T, Seifert B, Zollinger A, Camenzind V, Pasch T, Spahn DR: Low- and medium-molecular-weight hydroxyethyl starches: Comparison of their effect on blood coagulation. ANESTHESIOLOGY 2000; 93:1231-7
12. Kapiotis S, Quehenberger P, Eichler HG, Scharzinger I, Partan CP, Schneider B, Lechner K, Speiser W: Effect of hydroxyethyl starch on the activity of blood coagulation and fibrinolysis in healthy volunteers: Comparison with albumin. Crit Care Med 1994; 22:606-12
13. Jones SB, Whitten CW, Despotis GJ, Monk TG: The influence of crystalloid and colloid replacement solutions in acute normovolemic hemodilution: A preliminary survey of hemostatic markers. Anesth Analg 2003; 96:363-8
14. Conroy JM, Fishman RL, Reeves ST, Pinosky ML, Lazarchick J: The effects of desmopressin and 6% hydroxyethyl starch on factor VII:C. Anesth Analg 1996; 83:804-7
15. Claes Y, Van Hemelrijck, J, Van Gerven M, Arnout J, Vermylen J, Weider B, Van Aken H: Influence of hydroxyethyl starch on coagulation in patients during the perioperative period. Anesth Analg 1992; 75:24-30
16. Gandhi S, Warltier D, Weiskopf R, Bepperling F, Baus D, Jungheinrich C: Volume substitution therapy with HES 130/0.4 (Voluven) vs HES 450/0.7 (hetastarch) during major orthopedic surgery (abstract). Crit Care 2005; 9:P206
17. Neff TA, Doelberg M, Jungheinrich C, Sauerland A, Spahn DR, Stocker R: Repetitive large-dose infusion of the novel hydroxyethyl starch 130/0.4 in patients with severe head injury. Anesth Analg 2003; 96:1453-9
18. Kasper SM, Meinert P, Kampe S, Gorg C, Geisen C, Mehlhorn U, Diefenbach C: Large-dose hydroxyethyl starch 130/0.4 does not increase blood loss and transfusion requirements in coronary artery bypass surgery compared with hydroxyethyl starch 200/0.5 at recommended doses. ANESTHESIOLOGY 2003; 99:42-7
19. Kuitunen AH, Hynynen MJ, Vahtera E, Salmenpera MT: Hydroxyethyl starch as a priming solution for cardiopulmonary bypass impairs hemostasis after cardiac surgery. Anesth Analg 2004; 98:291-7
20. Huttner I, Boldt J, Haisch G, Suttner S, Kumle B, Schulz H: Influence of different colloids on molecular markers of haemostasis and platelet function in patients undergoing major abdominal surgery. Br J Anaesth 2000; 85:417-23
21. Gallandat-Huet RC, Siemons AW, Baus D, van Rooyen-Butijin WT, Haagenaars JA, van Oeveren W, Bepperling F: A novel hydroxyethyl starch (Voluven) for effective perioperative plasma volume substitution in cardiac surgery. Can J Anaesth 2000; 47:1207-15
22. Innerhofer P, Fries D, Margreiter J, Klingler A, Kühbacher G, Wachter B, Oswald E, Salner E, Frischhut B, Schobersberger W: The effects of perioperatively administered colloids and crystalloids on primary platelet-mediated hemostasis and clot formation. Anesth Analg 2002; 95:858-65
23. Petroianu GA, Maleck WH, Koetter KP, Liu J, Schmitt A: Effect of in vitro hemodilution with hydroxyethyl starch and dextran on the activity of plasma clotting factors. Crit Care Med 2003; 31:250-4
24. Franz A, Bräunlich P, Gamsjäger T, Felfernig M, Gustorff B, Kozek-Langenecker S: The effects of hydroxyethyl starches of varying molecular weight on platelet function. Anesth Analg 2001; 92:1402-7
25. Stögermüller B, Stark J, Willschke H, Felfernig M, Hörauf K, Kozek-Langenecker S: The effects of hydroxyethyl starch 200 kD on platelet function. Anesth Analg 2000; 91:823-7
26. Scharbert G, Deusch E, Kress HG, Greher M, Gustorff B, Kozek-Langenecker S: Inhibition of platelet function by hydroxyethyl starch solutions in chronic pain patients undergoing peridural anesthesia. Anesth Analg 2004; 99: 823-7
27. Deusch E, Thaler U, Kozek-Langenecker SA: The effects of high molecular weight hydroxyethyl starch solutions on platelets. Anesth Analg 2004; 99:665-8
28. Omar MN, Shouk TA, Khaleq MA: Activity of blood coagulation and fibrinolysis during and after hydroxyethyl starch (HES) colloidal volume replacement. Clin Biochem 1999; 32:269-74
29. Boldt J, Haisch G, Suttner S, Kumle B, Schellhaass A: Effects of a new modified, balanced hydroxyethyl starch preparation (Hextend) on measures of coagulation. Br J Anaesth 2002; 89:722-8
30. Jamnicki M, Zollinger A, Seifert B, Popovic D, Pasch T, Spahn DR: Compromised blood coagulation: An in vitro comparison of hydroxyethyl starch 130/0.4 and hydroxyethyl starch 200/0.5 using thrombelastography. Anesth Analg 1998; 87:989-93
31. Niemi TT, Kuitunen AH: Artificial colloids impair haemostasis: An in vitro study using thromboelastometry coagulgation analysis. Acta Anaesthesiol Scand 2005; 49:373-8
32. Gamsjäger T, Gustorff B, Kozek-Langenecker SA: The effects of hydroxyethyl starches on intracellular calcium in platelets. Anesth Analg 2002; 95:866-9
33. Jüttner B, Kuse ER, Elsner HA, Heine J, Jaeger K, Piepenbrock S, Scheinichen D: Differential platelet receptor expression following hydroxyethyl starch infusion in thrombocytopaenic orthotopic liver transplantation recipients. Eur J Anaesthesiol 2004; 21:309-13
34. Deusch E, Gamsjäger T, Kress HG, Kozek-Langenecker S: Binding of hydroxyethyl starch molecules to the platelet surface. Anesth Analg 2003; 97: 680-3
35. Strauss RG, Stansfield C, Henriksen RA, Villhauer PJ: Pentastarch may cause fewer effects on coagulation than hetastarch. Transfusion 1988; 28:257-60
36. Fries D, Innerhofer P, Klingler A, Berresheim U, Mittermayr M, Calatzis A, Schobersberger W: The effects of the combined administration of colloids and lactated Ringer's solution on the coagulation system: An in vitro study using thrombelastograph coagulation analysis (ROTEG). Anesth Analg 2002; 94:1280-7
37. Roberts J, Evans P, Bunn F, Kwan I, Crowhurst E: Is the normalisation of blood pressure in bleeding trauma patients harmful? (review). Lancet 2001; 357:385-7
38. Wilkes MM, Navickis RJ, Sibbald WJ: Albumin versus hydroxyethyl starch in cardiopulmonary bypass surgery: A meta-analysis of postoperative bleeding. Ann Thorac Surg 2001; 72:527-37
39. Boldt J, Knothe C, Zickmann B, Andres P, Dapper F, Hempelmann G: Influence of different intravascular volume therapies on platelet function in patients undergoing cardiopulmonary bypass. Anesth Analg 1993; 76:1185-90
40. Kuitunen A, Hynynen M, Salmenpera M, Heinonen J, Vahtera E, Verkkala K, Myllyla G: Hydroxyethyl starch as a prime for cardiopulmonary bypass: Effects of two different solutions on haemostasis. Acta Anaesthesiol Scand 1993; 37: 652-8
41. Avidan MS, Alcock EL, Da Fonseca J, Ponte J, Desai JB, Despotis GJ, Hunt BJ: Comparison of structured use of routine laboratory tests or near-patient assessment with clinical judgement in the management of bleeding after cardiac surgery. Br J Anaesth 2004; 92:178-86
42. Langeron O, Doelberg M, Ang ET, Bonnet F, Capdevila X, Coriat P: Voluven, a lower substituted novel hydroxyethyl starch (HES 130/0.4), causes fewer effects on coagulation in major orthopedic surgery than HES 200/0.5. Anesth Analg 2001; 92:855-62
43. James MFM, Latoo MY, Mythen MG: Plasma volume changes associated with two hydroxyethyl starch colloids following acute hypovolemia in volunteers. Anaesthesia 2004; 59:738-42
44. Leuschner J, Opitz J, Winkler A, Scharpf R, Bepperling F: Tissue storage of HC-labelled hydroxyethyl starch (HES) 130/0.4 and HES 200/0.5 after repeated intravenous administration to rats. Drugs R D 2003; 4:331-8
45. de Jonge E, Levi M: Effects of different plasma substitutes on blood coagulation: A comparative review. Crit Care Med 2001; 29:1261-7
46. Thaler U, Deusch E, Kozek-Langenecker S: In vitro effects of various gelatin solutions on platelet function and their comparison to hydroxyethyl starch solutions. Anaesthesia 2005; 60:554-9